2012 State of the Science of Endocrine Disrupting Chemicals by WHO, in collaboration with international experts.
CLARITY-BPA research program launched by FDA, NIEHS, and NTP.
Schug, T. T., Heindel, J. J., Camacho, L., Delclos, K. B., Howard, P., Johnson, A. F., Aungst, J., Keefe, D., Newbold, R., Walker, N. J., Thomas Zoeller, R., & Bucher, J. R. (2013). A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program. Reproductive toxicology (Elmsford, N.Y.), 40, 35–40.
Issues of low doses and non-monotonicity receives focus
Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Jr, Lee, D. H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., Zoeller, R. T., & Myers, J. P. (2012). Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine reviews, 33(3), 378–455.
EU Biocidal Products Regulation (EU) No 528/2012 and Commission Regulation (EU) 2017/2100. Excludes pesticides that have: “ active substances which, on the basis of the criteria specified ….are considered as having endocrine-disrupting properties that may cause adverse effects in humans…”
Food Packaging Forum founded by Dr. Jane Muncke.
Programmed to be Fat airs on The Nature of Things.